Canopy growth corp CGC.US Overview Analysis

US StockHealth Care
(No presentation for CGC)

CGC AI Analysis Overview

Keys for Bullish View

  • Value≥4
  • Dividend≥2

Analysis Conclusion

The stock has a lower value rating; if aiming for value investing, existing long-term positions might require gradual reduction.

CGC Current Performance

3.88%

Canopy growth corp

1.31%

Avg of Sector

0.58%

S&P500

Top 10 High Relevance to CGC

  • XTLB Xtl biopharmaceuticals limited
    Value 3Trend 3Swing Trading 2Whale Interest -Dividend 1
    See more

CGC Profile

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

Price of CGC